Evaluation of 3,4-methylenedioxyamphetamine (MDA) as an adjunct to psychotherapy.
D000661:Amphetamine / Q000494:pharmacology*; D001519:Behavior / Q000187:drug effects*; D003861:Depersonalization; D004644:Emotions / Q000187:drug effects; D005260:Female; D006213:Hallucinogens / Q000494:pharmacology*; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D010465:Perception / Q000187:drug effects; D011613:Psychotherapy
D006213:Hallucinogens; D008238:Lysergic Acid Diethylamide; D000661:Amphetamine